Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.76NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.385NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.384NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GN.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.424NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AH.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.327NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.396NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.129NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AK.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.224NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.618NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.458NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
W.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.264.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.338NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.20.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.80NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CZ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used